Swedish Orphan Biovitrum
kr 440.40Change from previous close: +0.87%Absolute change: +kr 3.80
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- kr 151.17B
- Enterprise value
- kr 167.37B
- P/E (trailing 12 months)
- 110.8
- Forward P/E
- 27.9
- PEG
- 0.26
- Price/book
- 3.57
- Price/sales
- 4.94
- EV/EBITDA
- 13.5
- EV/revenue
- 5.47
Profitability and growth
- Gross margin
- 78.5%
- Operating margin
- 25.3%
- Net margin
- 4.5%
- ROE
- 3.4%
- ROA
- 7.7%
- Revenue growth (year over year)
- 27.0%
- Earnings growth (year over year)
- 71.6%
Financial health
- Total cash
- kr 1.08B
- Total debt
- kr 17.59B
- Debt/equity
- 0.42
- Current ratio
- 0.88
- Quick ratio
- 0.55
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- kr 500.92
- Median price target
- kr 507.50
- High price target
- kr 590.00
- Low price target
- kr 350.00
- Analysts with a price target
- 12
- Consensus
- Buy
- Forward EPS
- kr 15.55
- EPS estimate, current year
- kr 19.47
Shares and trading
- Beta
- 0.27
- Average volume
- 353.03K
- Shares outstanding
- 348M
- Float
- 223.46M
- Institutional ownership
- 75.7%
- Insider ownership
- 9.8%